Holmes Biopharma, Inc. (LMB) Misses Q1 EPS by 65c, Slight Beat on Revenues; Boosts FY19 Revenue Outlook
Go back to Holmes Biopharma, Inc. (LMB) Misses Q1 EPS by 65c, Slight Beat on Revenues; Boosts FY19 Revenue Outlook| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 52.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.21 | 52 Week High | $0.15 | |||
| Open | $52.21 | 52 Week Low | $0.15 | |||
| Day High | $52.21 | P/E | N/A | |||
| Day Low | $52.21 | EPS | $0.00 | |||
| Volume | 50 | |||||
